Xelpros (latanoprost ophthalmic emulsion) 0.005%, 125mcg/2.5mL, 2.5 mL bottle, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., India., NDC 47335-317-90
Published May 29, 2024 · Recall initiated: April 22, 2024
Summary
FDA records drug Class III recall D-0502-2024, published May 29, 2024 and initiated April 22, 2024. Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC; Status: Ongoing; Reported quantity: 35,069 bottles; Lot: Lot #: HAD3383A, Exp 8/31/2024. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Release Testing: Out of specification for particulate matter test.
What to do
Voluntary: Firm initiated · Letter
Get an email if XELPROS has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- XELPROS
- Manufacturer
- SUN PHARMACEUTICAL INDUSTRIES INC
- Distributor
- TX, PA
- Lot
- Lot #: HAD3383A, Exp 8/31/2024
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAniCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 x 10 mL Single Dose Vials, Rx Only, ForMay 29, 2024
- FDASirolimus Tablets 1mg Tablets 100-count bottle, Rx Only, Distributed by: Dr. Reddy's Laboratories Inc.,May 29, 2024
- FDADuloxetine Delayed-Release Cap USP 30mg, 30-count bottle, Rx only, Preferred Pharmaceutcals, Inc., NDCMay 29, 2024
- FDACardinalHealth Curity Flexible Adhesive Bandage X-Large 2 x 3.75 in. (5.1 x 9.5 cm), Model 44102, Sterile,May 22, 2024
- FDAReagent Test Strips for Blood, Urobilinogen, Bilirubin, Protein, Nitrite, Ketones, Ascorbic Acid, Glucose, pH,May 22, 2024
- FDAEchoTip® Ultra Endoscopic Ultrasound Access Needle, ECHO-19, G31520May 22, 2024
Questions about this recall
Was Xelpros (latanoprost ophthalmic emulsion) 0.005%, 125mcg/2.5mL, 2.5 mL bottle, Rx only, Manufactured by: Sun Pharmaceutical Ind. Ltd., India., NDC 47335-317-90 recalled?
Yes. FDA published recall D-0502-2024 on May 29, 2024. Reported hazard: Failed Release Testing: Out of specification for particulate matter test.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: XELPROS.